José Antonio García Erce: Which Oral Iron Therapy Should We Choose?
José Antonio García Erce, Vocal-elect of the Board of the Spanish Society of Hematology and Hemotherapy, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
“We are honoured to have published this review with Drs. Santiago García Lopez and Antonio Martínez-Francés in a special issue of Journal of Clinical Medicine (JCM) MDPI: Special Issue Clinical Updates in Transfusion Medicine and Patient Blood Management) open to receive more papers.
Our thanks to Dr Salvador Payán-Pernía for his thorough professional critique which has been instrumental in improving this work”
Title: Iron Deficiency and Oral Treatments: Limitations, Pharmacokinetics, and the Role of Iron Protein Succinylate in Clinical Practice
Authors: José Antonio García-Erce, Santiago García-López, Antonio Martínez-Francés
Other posts featuring José Antonio García Erce on Hemostasis Today.
-
Sep 25, 2026, 12:43Thomas Dayspring: Reshaping the Biology of Atherosclerotic Plaques with New Therapies
-
Sep 25, 2026, 12:14Garima Sharma: Community Clinical Linkages for Better Postpartum Cardiovascular Care
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis